Lupin Limited (BOM:500257)
1,892.70
-3.05 (-0.16%)
At close: Jul 11, 2025
Lupin Employees
Lupin had 19,210 employees as of March 31, 2024. The number of employees decreased by 1,723 or -8.23% compared to the previous year.
Employees
19,210
Change (1Y)
-1,723
Growth (1Y)
-8.23%
Revenue / Employee
11.82M INR
Profits / Employee
1.71M INR
Market Cap
864.43B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 19,210 | -1,723 | -8.23% |
Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
Mar 31, 2021 | 18,573 | 271 | 1.48% |
Mar 31, 2020 | 18,302 | 618 | 3.49% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Reliance Industries | 347,362 |
HDFC Bank | 214,521 |
Tata Consultancy Services | 607,979 |
Bharti Airtel | 28,673 |
ICICI Bank | 187,765 |
State Bank of India | 236,226 |
Infosys | 323,578 |
Hindustan Unilever | 18,802 |
Lupin News
- 9 days ago - Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market - Business Upturn
- 12 days ago - Lupin gets USFDA nod for Loteprednol Etabonate Ophthalmic Gel; Eligible for 180-day generic exclusivity - Business Upturn
- 12 days ago - Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market - Business Upturn
- 27 days ago - Lupin shares in focus as company signs respiratory drug deal in China with Sino Universal - Business Upturn
- 5 weeks ago - Lupin gets U.S. FDA tentative approval for Generic Oxcarbazepine ER Tablets - Business Upturn
- 6 weeks ago - Lupin to present Phase 1 data on LNP7457 cancer drug at ASCO 2025 - Business Upturn
- 6 weeks ago - Lupin and SteinCares sign license and supply agreement for Ranibizumab in Latin America - Business Upturn
- 2 months ago - Lupin secures FDA approval for Rivaroxaban 10 mg, 15 mg and 20 mg tablets - Business Upturn